Advanced search

The endoplasmic reticulum: A target for new anticancer drugs

Jerina Boelens (UGent) , Sofie Lust (UGent) , Fritz Offner (UGent) , Marc Bracke (UGent) and Barbara Vanhoecke (UGent)
(2007) IN VIVO. 21(2). p.215-226
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Boelens, Jerina, Sofie Lust, Fritz Offner, Marc Bracke, and Barbara Vanhoecke. 2007. “The Endoplasmic Reticulum: A Target for New Anticancer Drugs.” In Vivo 21 (2): 215–226.
APA
Boelens, Jerina, Lust, S., Offner, F., Bracke, M., & Vanhoecke, B. (2007). The endoplasmic reticulum: A target for new anticancer drugs. IN VIVO, 21(2), 215–226.
Vancouver
1.
Boelens J, Lust S, Offner F, Bracke M, Vanhoecke B. The endoplasmic reticulum: A target for new anticancer drugs. IN VIVO. INT INST ANTICANCER RESEARCH; 2007;21(2):215–26.
MLA
Boelens, Jerina, Sofie Lust, Fritz Offner, et al. “The Endoplasmic Reticulum: A Target for New Anticancer Drugs.” IN VIVO 21.2 (2007): 215–226. Print.
@article{391901,
  author       = {Boelens, Jerina and Lust, Sofie and Offner, Fritz and Bracke, Marc and Vanhoecke, Barbara},
  issn         = {0258-851X},
  journal      = {IN VIVO},
  language     = {eng},
  number       = {2},
  pages        = {215--226},
  publisher    = {INT INST ANTICANCER RESEARCH},
  title        = {The endoplasmic reticulum: A target for new anticancer drugs},
  volume       = {21},
  year         = {2007},
}

Web of Science
Times cited: